Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer

ABSTRACT: Explore the efficacy of radiotherapy combined with Tislelizumab and irinotecan in MSS/pMMR inoperable recurrent and metastatic colorectal cancer patients; To evaluate the safety and tolerability of radiotherapy combined with Tislelizumab and irinotecan in MSS/pMMR inoperable recurrent and metastatic colorectal cancer; To evaluate the radiosensitization effects of Tslelizumab and irinotecan;

DISEASE(S): Colorectal Cancer,Colorectal Cancer Metastatic,Colorectal Neoplasms,Microsatellite Stable,Mismatch Repair-proficient

PROVIDER: 2398597 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR